AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome

Added 36 days ago (21.10.2021)
Authors: Peng Li; Thomas White; Wei Xie; Wei Cui; Deniz Peker; Gang Zeng; Huan-You Wang; Jennie Vagher; Sara Brown; Margaret Williams; Tibor Kovacsovics; Jay L. Patel
Journal: Leukemia
Read article